Stay updated on Nivolumab in CNS and Testicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page
- Check2 days agoChange DetectedThe page header/footer version has been updated from v3.5.2 to v3.5.3, reflecting a software/interface release rather than an update to the trial information.SummaryDifference0.0%

- Check9 days agoChange DetectedUpdated collaborator listing from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd., and updated the revision to v3.5.2 (replacing v3.5.0).SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This reflects an incremental system update and does not modify study content or user-facing features.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded Revision: v3.4.2 and removed the earlier Revision: v3.4.1 notice about government funding and operating status.SummaryDifference0.3%

- Check81 days agoChange DetectedA site-wide funding status notice was added, informing users that information may not be up to date; the page revision was updated to v3.4.1, replacing the previous v3.4.0 version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab in CNS and Testicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.